These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25669692)

  • 1. Increased plasma levels of the high mobility group box 1 protein (HMGB1) are associated with a higher score of gastrointestinal dysfunction in individuals with autism.
    Babinská K; Bucová M; Ďurmanová V; Lakatošová S; Jánošíková D; Bakoš J; Hlavatá A; Ostatníková D
    Physiol Res; 2014; 63(Suppl 4):S613-8. PubMed ID: 25669692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of high mobility group box 1 protein in patients with autistic disorder.
    Emanuele E; Boso M; Brondino N; Pietra S; Barale F; Ucelli di Nemi S; Politi P
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):681-3. PubMed ID: 20302902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Association Between Plasma Levels of Advanced Glycation and Precursor of Lipoxidation end Products with Gastrointestinal Problems in Children with Autism.
    Ghodsi R; Kheirouri S
    Curr Pediatr Rev; 2019; 15(3):184-190. PubMed ID: 31264551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins.
    de Souza AW; van der Geest KS; Brouwer E; Pinheiro FA; Oliveira AC; Sato EI; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Arthritis Res Ther; 2015 Jun; 17(1):158. PubMed ID: 26062541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis.
    Kocsis AK; Szabolcs A; Hofner P; Takács T; Farkas G; Boda K; Mándi Y
    Pancreatology; 2009; 9(4):383-91. PubMed ID: 19451748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: A pilot study.
    Marie-Claire C; Courtin C; Curis E; Bouaziz-Amar E; Laplanche JL; Jacob A; Etain B; Blanchard A; Bellivier F
    J Neuroimmunol; 2019 Sep; 334():576993. PubMed ID: 31203140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis.
    Bucova M; Majernikova B; Durmanova V; Cudrakova D; Gmitterova K; Lisa I; Klimova E; Kluckova K; Buc M
    Neurol Sci; 2020 Mar; 41(3):599-604. PubMed ID: 31728855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of plasma high mobility group box-1 in disseminated intravascular coagulation with leukemia.
    Wang M; Mei H; Kou H; Deng J; Wang H; Guo T; Hu Y
    Thromb Res; 2015 Aug; 136(2):422-6. PubMed ID: 26049171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury.
    Papatheodorou A; Stein A; Bank M; Sison CP; Gibbs K; Davies P; Bloom O
    J Neurotrauma; 2017 Feb; 34(3):746-754. PubMed ID: 27673428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome.
    Palmblad K; Schierbeck H; Sundberg E; Horne AC; Harris HE; Henter JI; Antoine DJ; Andersson U
    Mol Med; 2015 Jan; 20(1):538-47. PubMed ID: 25247290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 as a new biomarker of celiac disease in children: A multicenter study.
    Manti S; Cuppari C; Tardino L; Parisi G; Spina M; Salpietro C; Leonardi S
    Nutrition; 2017 May; 37():18-21. PubMed ID: 28359357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention.
    Jyonouchi H; Geng L; Ruby A; Zimmerman-Bier B
    Neuropsychobiology; 2005; 51(2):77-85. PubMed ID: 15741748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects.
    Esnafoglu E; Cırrık S; Ayyıldız SN; Erdil A; Ertürk EY; Daglı A; Noyan T
    J Pediatr; 2017 Sep; 188():240-244. PubMed ID: 28502607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of high-mobility group box-1 (HMGB1) in patients with severe or uncomplicated Plasmodium falciparum malaria.
    Angeletti D; Kiwuwa MS; Byarugaba J; Kironde F; Wahlgren M
    Am J Trop Med Hyg; 2013 Apr; 88(4):733-5. PubMed ID: 23400574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation.
    Hatada T; Wada H; Nobori T; Okabayashi K; Maruyama K; Abe Y; Uemoto S; Yamada S; Maruyama I
    Thromb Haemost; 2005 Nov; 94(5):975-9. PubMed ID: 16363239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy.
    Momonaka H; Hasegawa S; Matsushige T; Inoue H; Kajimoto M; Okada S; Nakatsuka K; Morishima T; Ichiyama T
    Brain Dev; 2014 Jun; 36(6):484-8. PubMed ID: 23907181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is HMGB1 a new indirect marker for revealing fibrosis in chronic hepatitis and a new therapeutic target in treatment?
    Albayrak A; Uyanik MH; Cerrah S; Altas S; Dursun H; Demir M; Uslu H
    Viral Immunol; 2010 Dec; 23(6):633-8. PubMed ID: 21142449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum/plasma high mobility group box 1 with autoimmune diseases: A systematic review and meta-analysis.
    Zhu B; Zhu Q; Li N; Wu T; Liu S; Liu S
    Medicine (Baltimore); 2018 Jul; 97(29):e11531. PubMed ID: 30024540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
    Jung JY; Suh CH; Sohn S; Nam JY; Kim HA
    Clin Rheumatol; 2016 Aug; 35(8):1937-1942. PubMed ID: 27225247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.